Data Foundry

Drug recalls 2015

Duloxetine Delayed-release Capsules — Class III drug recall D-0181-2016

Terminated recall by Breckenridge Pharmaceutical, Inc, reported 2015-11-18, distributed nationwide. Presence of Foreign Tablets/Capsules: one foreign capsule identified as omeprazole 10 mg was found in the bott

Recall numberD-0181-2016
Product typeDrug
ClassificationClass III
StatusTerminated
Voluntary or mandatedVoluntary
Recalling firmBreckenridge Pharmaceutical, Inc, Berlin, CT, United States
Recall initiated2015-10-21
Classified2015-11-10
Reported by FDA2015-11-18
Terminated2015-12-24
DistributedNationwide (US)
Quantity595 bottles
NDC51991-0746, 51991-0746-05, 51991-0746-06, 51991-0746-90, 51991-0747, 51991-0747-10, 51991-0747-33, 51991-0747-90, 51991-0748, 51991-0748-10, 51991-0748-33, 51991-0748-90, 51991-0750, 51991-0750-05, 51991-0750-10, 51991-0750-33, 51991-0750-90
Lot numbers142391
Expiration dates2016-10

Product

Duloxetine Delayed-release Capsules, USP, 60 mg, Rx Only, 1000 count bottle, Manufactured by: Laboratorios Dr. Esteve, S.A., Barcelona, Spain, Distributed by: Breckenridge Pharmaceutical, Inc., Boca Raton, FL 33487, NDC: 51991-748-10

Reason for recall

Presence of Foreign Tablets/Capsules: one foreign capsule identified as omeprazole 10 mg was found in the bottle

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0181-2016. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.